Wells Fargo’s Cellectar Biosciences CLRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-205
| Closed | -$816 | – | 6581 |
|
|
2024
Q1 | $816 | Buy |
205
+145
| +242% | +$577 | ﹤0.01% | 5800 |
|
|
2023
Q4 | $166 | Sell |
60
-11
| -15% | -$30 | ﹤0.01% | 6209 |
|
|
2023
Q3 | $188 | Buy |
71
+11
| +18% | +$29 | ﹤0.01% | 6225 |
|
|
2023
Q2 | $117 | Buy |
60
+4
| +7% | +$8 | ﹤0.01% | 6525 |
|
|
2023
Q1 | $80 | Buy |
56
+1
| +2% | +$1 | ﹤0.01% | 6662 |
|
|
2022
Q4 | $94 | Buy |
55
+16
| +41% | +$27 | ﹤0.01% | 6481 |
|
|
2022
Q3 | $0 | Sell |
39
-356
| -90% | – | ﹤0.01% | 6390 |
|
|
2022
Q2 | $0 | Buy |
395
+30
| +8% | – | ﹤0.01% | 6555 |
|
|
2022
Q1 | $0 | Buy |
365
+1
| +0.3% | – | ﹤0.01% | 6707 |
|
|
2021
Q4 | $0 | Sell |
364
-2,981
| -89% | – | ﹤0.01% | 6690 |
|
|
2021
Q3 | $3K | Buy |
3,345
+23
| +0.7% | +$21 | ﹤0.01% | 6149 |
|
|
2021
Q2 | $4K | Buy |
3,322
+11
| +0.3% | +$13 | ﹤0.01% | 6049 |
|
|
2021
Q1 | $6K | Buy |
3,311
+154
| +5% | +$279 | ﹤0.01% | 6078 |
|
|
2020
Q4 | $6K | Buy |
3,157
+10
| +0.3% | +$19 | ﹤0.01% | 5814 |
|
|
2020
Q3 | $4K | Buy |
3,147
+123
| +4% | +$156 | ﹤0.01% | 5713 |
|
|
2020
Q2 | $4K | Sell |
3,024
-1,000
| -25% | -$1.32K | ﹤0.01% | 5640 |
|
|
2020
Q1 | $5K | Buy |
+4,024
| New | +$5K | ﹤0.01% | 5546 |
|
|
2018
Q3 | – | Sell |
-5
| Closed | – | – | 5900 |
|
|
2018
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 5899 |
|
|
2018
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 5893 |
|
|
2017
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 5859 |
|
|
2017
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 5868 |
|
|
2017
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 5805 |
|
|
2017
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 5833 |
|
|
2016
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 5823 |
|
|
2016
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 5813 |
|
|
2016
Q2 | $0 | Hold |
5
| – | – | ﹤0.01% | 5776 |
|
|
2016
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 5914 |
|